Ventus to Advance cGAS Inhibitor as New Treatment for Lupus
Ventus Therapeutics plans to develop a new treatment candidate for lupus and other inflammatory diseases marked by the activation of the type 1 interferon immune system pathway, the company recently announced. Called VENT-03, the investigational treatment will target cGAS, a protein whose activation has been implicated in…